Pharmaceutical

Biocytogen and Radiance partner for bispecific antibody-drug conjugate

Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.

Jan 9, 2024 - 18:00
Biocytogen and Radiance partner for bispecific antibody-drug conjugate
Biocytogen Pharmaceuticals and Radiance Biopharma have signed an exclusive option and licence agreement for a BsADC.
Read the original article

Tags:

Previous Article

MSD acquires Harpoon for $680m to strengthen T-cell engager armoury

Next Article

BIOS Health to launch precision medicine centre in California, US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

argenx wins EMA CHMP nod for subcutaneous Vyvgart in myasthenia gravis

argenx wins EMA CHMP nod for subcutaneous Vyvgart in my...

Sep 15, 2023

STAT+: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million

STAT+: Six months after launch, Bert Vogelstein’s lates...

Apr 27, 2023

STAT+: Medicare’s new pay boost for primary care is angering specialists

STAT+: Medicare’s new pay boost for primary care is ang...

Nov 11, 2023